Capra Biosciences Raises $1.8M in Pre-Seed Funding

Capra Biosciences, a Manassas, VA-based company focused on sustainable production of petrochemical replacements using their biofilm bioreactor platform, raised $1.8m in pre-seed funding.

Pre-seed investors include Prithvi Ventures; the E14 Fund; GS Futures; Antimo’s president – Wes Osbourn; Savantus Ventures; Asymmetry Ventures; the Decarbonization Consortium; and SOSV, among others.

The company intends to use the funds to build its production-scale reactor and extend its capabilities to include the production of lubricants.

Co-founded by Elizabeth Onderko, CEO, and Andrew Magyar, chief technology officer, Capra Biosciences works at the intersection of biology and hardware engineering to build a new kind of continuous flow bioreactor that leverages the unique features of their platform organism. Its first product is retinol, a cosmetic ingredient used in anti-aging products. Located in the Prince William Science Accelerator, the company emerged from the competitive IndieBio program backed by SOSV.

Get latest news from African Startup ecosystem

Latest stories

You might also like...